Edition:
United States

Alchemia Ltd (ACL.AX)

ACL.AX on Australia Stock Exchange

0.01AUD
22 Sep 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.01
Open
$0.01
Day's High
$0.01
Day's Low
$0.01
Volume
277,626
Avg. Vol
346,676
52-wk High
$0.01
52-wk Low
$0.01

Chart for

About

Alchemia Limited is a biotechnology company. The Company is engaged in the sale of its around the world intellectual property rights to Fondaparinum sodium, a generic anti-coagulant drug to Dr Reddy's Laboratories; closure of clinical trial activities, and review of new opportunities. The Company's segments include Fondaparinux... (more)
No analyst recommendations are available for .

Overall

Beta: -0.47
Market Cap(Mil.): $2.60
Shares Outstanding(Mil.): 324.72
Dividend: 0.09
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 80.89 16.34
EPS (TTM): -- -- --
ROI: -- 3.08 14.66
ROE: -- 4.82 14.00

Earnings vs. Estimates